Also known as: Daurismo
Glasdegib is a Hedgehog (Hh) pathway inhibitor that blocks the Smoothened (SMO) protein, used in combination with low-dose cytarabine for treatment of newly diagnosed acute myeloid leukemia (AML). Mediocon Inc supplies pharmaceutical-grade Glasdegib API.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | ≥98.0% (as per pharmacopoeia) |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |